Related Experiment Video
Updated: May 20, 2026
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Uncommon foreign body reaction caused by botulinum toxin
Helder Antonio Rebelo Pontes1, Flávia Sirotheau Correa Pontes, Glauber Freitas de Oliveira
1Department of Surgery and Oral Pathology, João de Barros Barreto University Hospital, Belém, Brazil.
The Journal of Craniofacial Surgery
|July 18, 2012
Summary
Botulinum toxin type A (BTX-A) injections for cosmetic reasons can cause rare complications, such as maxillary masses, potentially hindering orthodontic treatment. Enhanced anatomical and pharmacological knowledge is crucial for safe BTX-A application.
Area of Science:
- * Investigates the clinical application and potential complications of Botulinum toxin type A (BTX-A) in cosmetic procedures.
- * Focuses on the intersection of aesthetic medicine, oral surgery, and patient safety.
Background:
- * Botulinum toxin, particularly type A (BTX-A), is widely used for cosmetic facial enhancements due to its efficacy and safety profile.
- * BTX-A is produced via Clostridium botulinum fermentation and has multiple antigenic subtypes, with BTX-A being the only one approved for cosmetic use.
- * Its application is increasingly common in oral and maxillofacial surgery for aesthetic purposes.
Observation:
- * Reports an unusual complication following cosmetic BTX-A injection in the upper lip.
- * The complication involved the formation of a mass in the anterior maxilla.
- * This mass subsequently interfered with and caused failure in orthodontic treatment.
Findings:
- * Cosmetic BTX-A injections, despite their common use, can lead to unforeseen adverse events.
- * The development of a maxillary mass is a rare but significant complication.
- * Such complications can negatively impact the success of concurrent orthodontic therapies.
Implications:
- * Highlights the necessity for enhanced understanding of BTX-A's anatomical, pharmacological, and dosage parameters before cosmetic application.
- * Emphasizes the importance of thorough patient evaluation and risk assessment in aesthetic procedures.
- * Suggests a need for improved surgical and injection techniques to mitigate rare complications in cosmetic and maxillofacial surgery.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:28Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...